Amerinet Contracts With Medrad, Inc. For Full Line Of MR, CT And Cardiovascular Products

INDIANOLA, Pa., Dec. 19 /PRNewswire/ -- Amerinet has signed a comprehensive agreement with MEDRAD, INC. for vascular injection systems and related disposables used in Computed Tomography (CT), Magnetic Resonance (MR) and Cardiovascular (CV) imaging. The agreement also includes MEDRAD's full line of MR-compatible patient care products and surface coils.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO)

The agreement will provide Amerinet's 1,860 acute care affiliates with access to savings on one of the most comprehensive line of medical imaging accessories offered by a single manufacturer. "This new contract with MEDRAD is a win for Amerinet's members and their patients," said Tom Emmerson, RT, Amerinet senior contract manager. "This is the most comprehensive offering that Amerinet has ever had with MEDRAD. Each year they exceed our expectations of product offering and support."

MEDRAD introduced the first vascular injection systems used in CT, MR and cardiovascular imaging procedures, and maintains 98 percent customer satisfaction ratings in North America for product quality and reliability. Amerinet members will be supported by MEDRAD's field sales, equipment service and application specialist teams, who provide a full spectrum of onsite expertise and seamless customer interface.

MEDRAD, INC. is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD's product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services. Total 2004 revenues were $343 million. MEDRAD is a 2003 recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a U.S. affiliate of Schering AG, Germany . For more information, visit MEDRAD's website at www.medrad.com.

Amerinet is one of the most innovative and effective health care group purchasing organizations in the United States, partnering with members to improve their operating margins. Amerinet leads the industry in flexibility with a commitment to providing supplier choice for its members. Amerinet has set the standard for customer service for nearly two decades. More than 1,860 hospitals and 21,000 non-acute care facilities find cost savings and value- added services through Amerinet's comprehensive contract portfolio. Members trust Amerinet to deliver proactive information and integrity. Amerinet's corporate offices are located in St. Louis, MO. For more information, visit their website at www.amerinet-gpo.com.

Cautionary statement regarding forward-looking statements.

Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and MEDRAD's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. MEDRAD undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events, circumstances or otherwise.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comMEDRAD, INC.

CONTACT: Tom L. Emmerson, R.T. Senior Contract Manager, DiagnosticImaging, Amerinet, Inc., +1-314-542-1916, or emmerson@amerinet-gpo.com ; orMike McKeogh, Corporate Accounts, +1-800-633-7231, ext. 8801, ormmckeogh@medrad.com , or Luanne Radermacher, Corporate Affairs,+1-412-767-2400, ext. 3184, or lradermacher@medrad.com , both of MEDRAD,INC.

MORE ON THIS TOPIC